REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 68 filers reported holding REDHILL BIOPHARMA LTD in Q4 2020. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $255,000 | -39.1% | 55,930 | -6.4% | 0.01% | -28.6% |
| Q2 2021 | $419,000 | -25.4% | 59,786 | -24.0% | 0.01% | -30.0% |
| Q1 2021 | $562,000 | +1.6% | 78,633 | +21.7% | 0.01% | -16.7% |
| Q4 2020 | $553,000 | -16.0% | 64,590 | +0.4% | 0.01% | -42.9% |
| Q3 2020 | $658,000 | +57.8% | 64,360 | +8.4% | 0.02% | +40.0% |
| Q2 2020 | $417,000 | +53.9% | 59,355 | -4.2% | 0.02% | +15.4% |
| Q1 2020 | $271,000 | -19.6% | 61,935 | +9.8% | 0.01% | +8.3% |
| Q4 2019 | $337,000 | -6.6% | 56,431 | +12.7% | 0.01% | -7.7% |
| Q3 2019 | $361,000 | +20.7% | 50,061 | +8.2% | 0.01% | +30.0% |
| Q2 2019 | $299,000 | -13.8% | 46,255 | +10.7% | 0.01% | -41.2% |
| Q1 2019 | $347,000 | +33.5% | 41,802 | -10.6% | 0.02% | +41.7% |
| Q4 2018 | $260,000 | -13.6% | 46,782 | +37.3% | 0.01% | +9.1% |
| Q3 2018 | $301,000 | +131.5% | 34,076 | +29.7% | 0.01% | +37.5% |
| Q1 2018 | $130,000 | +16.1% | 26,266 | +20.0% | 0.01% | 0.0% |
| Q4 2017 | $112,000 | -5.1% | 21,890 | +101.4% | 0.01% | -20.0% |
| Q3 2017 | $118,000 | +34.1% | 10,870 | +7.8% | 0.01% | +42.9% |
| Q2 2017 | $88,000 | – | 10,087 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 300 | $2,175 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |